SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Diabetes Metab J. 2022;46(5):667-674.

Blood Pressure Target in Type 2 Diabetes Mellitus.

,

제1저자 김현진 · 교신저자 김광일

소속 (2)
  1. Division of Cardiology, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
  2. Division of Geriatrics, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Abstract

The prevalence of diabetes mellitus continues to increase worldwide, and it is a well-established cardiovascular risk factor. Hypertension is also an important cardiovascular risk factor to be controlled and is common among patients with diabetes mellitus. Optimal blood pressure (BP) goals have been the subject of great debate in the management of hypertension among patients with diabetes mellitus. This review provides detailed results from randomized controlled trials and meta-analyses of clinical outcomes according to the target BP in patients with type 2 diabetes mellitus. In addition, the target BP in patients with diabetes mellitus recommended by different guidelines was summarized and presented. A target BP of <140/90 mm Hg is recommended for patients with hypertension and diabetes mellitus, and BP should be controlled to <130/80 mm Hg in patients with diabetes mellitus who have high-risk clinical features. We hope that this review will be helpful to clinicians and patients by promoting the understanding and appropriate application of BP control in the comprehensive management of patients with diabetes mellitus.

Keywords

Blood pressureCardiovascular diseasesDiabetes mellitusHypertension

Figures

Fig. 1.
Fig. 1. Optimal target blood pressure (BP) for general and high-risk clinical features in patients with diabetes mellitus. Considering these guidelines and studies, it is important to apply individualized target BP for patients with diabetes mellitus. SBP, systolic blood pressure; DBP, diastolic blood pressure; CV, cardiovascular.

그림 출처: PubMed Central 공개 논문 (PMC9532171)

Conflict of interest statement

CONFLICTS OF INTEREST . No potential conflict of interest relevant to this article was reported.

그 밖의 정보
출판 형태
Journal Article, Review, Research Support, Non-U.S. Gov't
저널
Diabetes & metabolism journal · eISSN 2233-6087
전자 출판
2022-09-19
MeSH
Antihypertensive Agents / therapeutic use · Blood Pressure · Diabetes Mellitus, Type 2* / complications / drug therapy / epidemiology · Humans · Hypertension* / complications / drug therapy / epidemiology
Substances
Antihypertensive Agents
참고문헌
29편